Literature DB >> 17644308

Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain.

Shanshan Feng1, Yonghui Yang, Yide Mei, Li Ma, De-e Zhu, Naseruddin Hoti, Mark Castanares, Mian Wu.   

Abstract

RIP3 (Receptor Interacting Protein 3), a member of the Ser/Thr kinase family, is able to induce apoptosis and activate NF-kappaB in various cell types. However, the detailed mechanism of RIP3-induced apoptosis is largely unknown. In this study, we show that RIP3 is cleaved at Asp328 by caspase-8 under apoptotic stimuli, which is blocked by pan-caspase inhibitor Z-VAD-FMK. In addition, full-length RIP3 induces both caspase-dependent and-independent apoptosis, as well as activates NF-kappaB. However, after cleavage, the C-terminus of RIP3 (aa 329-518) that lacks the kinase domain can form punctuate or filaments-like structures in cytoplasm, which induces only caspase-dependent apoptosis and exhibits a markedly higher NF-kappaB-activating activity than full-length RIP3. More importantly, the cleaved product of RIP3 (aa 329-518) displays better stability than wild type RIP3. Additionally, RIP3(K50A), a kinase-dead RIP3 mutant, also induces only caspase-dependent apoptosis along with an increased NF-kappaB-activating activity compared to RIP3, which further demonstrates that kinase activity of RIP3 is essential for its caspase-independent apoptotic activity. These results will help us to understand the mechanism underlying RIP3-induced apoptosis and the different roles of kinase domain and unique domain of RIP3.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17644308     DOI: 10.1016/j.cellsig.2007.05.016

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  203 in total

Review 1.  Programmed necrosis: backup to and competitor with apoptosis in the immune system.

Authors:  Jiahuai Han; Chuan-Qi Zhong; Duan-Wu Zhang
Journal:  Nat Immunol       Date:  2011-11-16       Impact factor: 25.606

2.  IAPs, TNF, inflammation and Jürg Tschopp; a personal perspective.

Authors:  J Silke; J E Vince
Journal:  Cell Death Differ       Date:  2012-01       Impact factor: 15.828

Review 3.  Non-apoptotic functions of apoptosis-regulatory proteins.

Authors:  Lorenzo Galluzzi; Oliver Kepp; Christina Trojel-Hansen; Guido Kroemer
Journal:  EMBO Rep       Date:  2012-04-02       Impact factor: 8.807

Review 4.  Cell Death Signaling.

Authors:  Douglas R Green; Fabien Llambi
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-12-01       Impact factor: 10.005

Review 5.  Necroptosis: A new way of dying?

Authors:  Britt Hanson
Journal:  Cancer Biol Ther       Date:  2016-07-19       Impact factor: 4.742

Review 6.  Photoreceptor cell death and rescue in retinal detachment and degenerations.

Authors:  Yusuke Murakami; Shoji Notomi; Toshio Hisatomi; Toru Nakazawa; Tatsuro Ishibashi; Joan W Miller; Demetrios G Vavvas
Journal:  Prog Retin Eye Res       Date:  2013-08-28       Impact factor: 21.198

7.  Temporal Pattern and Crosstalk of Necroptosis Markers with Autophagy and Apoptosis Associated Proteins in Ischemic Hippocampus.

Authors:  Fari Ryan; Fariba Khodagholi; Leila Dargahi; Dariush Minai-Tehrani; Abolhassan Ahmadiani
Journal:  Neurotox Res       Date:  2018-01-08       Impact factor: 3.911

Review 8.  Novel Ser/Thr protein phosphatases in cell death regulation.

Authors:  Haipeng Sun; Yibin Wang
Journal:  Physiology (Bethesda)       Date:  2012-02

Review 9.  Lytic cell death in metabolic liver disease.

Authors:  Jérémie Gautheron; Gregory J Gores; Cecília M P Rodrigues
Journal:  J Hepatol       Date:  2020-04-13       Impact factor: 25.083

Review 10.  Programmed necrosis in the cross talk of cell death and inflammation.

Authors:  Francis Ka-Ming Chan; Nivea Farias Luz; Kenta Moriwaki
Journal:  Annu Rev Immunol       Date:  2014-12-10       Impact factor: 28.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.